While emerging research suggests the omicron variant may be less likely to lead to severe disease, those who have long Covid say they desperately want to avoid reinfection.
in November in southern Africa. Therefore, it is too early to see how it will play out in the coming months.
Still, there is no evidence to suggest omicron would behave differently compared to previous variants. Covid resulted inOmicron's apparent propensity to cause less serious illness may provide a false sense of security, said Dr. Greg Vanichkachorn, medical director of the Mayo Clinic's Covid-19 Activity Rehabilitation Program in Rochester, Minnesota.
"Over three-quarters of our patients had very mild illnesses and then went on to develop long-haul Covid," he said.from the Penn State College of Medicine estimated that more than half of those with Covid will have symptoms for at least six months following their infection.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Don't Be Too Cavalier About Omicron -- Long Covid Is Still a Real RiskPresident Biden told the U.S. that if you’re triple vaxxed, you’re safe for the holidays. That’s not only not true, it’s dismissing almost 10 million Americans affected by a…
Weiterlesen »
Here's how long you need to isolate after testing positive for COVIDThere are calls for the CDC to change its guidelines on isolation periods for those who are vaccinated and infected with the disease.
Weiterlesen »
FDA authorizes Merck's COVID pill for some high-risk adultsThe Food and Drug Administration on Thursday authorized an antiviral pill developed by Merck and Ridgeback Biotherapeutics to treat some adults at high risk of becoming severely ill from COVID-19, despite concerns over its effectiveness and safety. Why it matters: Effective at-home antiviral drugs designed to prevent or treat COVID-19 could be key pandemic-fighting tools, especially as new variants emerge. Stay on top of the latest market trends and economic insights with Axios Markets. Subscrib
Weiterlesen »
FDA authorizes Pfizer COVID antiviral pill for high-risk individualsThe Food and Drug Administration on Wednesday authorized Pfizer's antiviral pill for the treatment of individuals at high risk of severe illness from COVID-19. Why it matters: At-home COVID-19 treatments, especially Pfizer's Paxlovid, are seen as possible game-changers for the pandemic. The emergency use authorization comes as the U.S. sees a surge in new COVID-19 cases and hospitalizations largely driven by the Omicron variant. Get market news worthy of your time with Axios Markets. Subscribe f
Weiterlesen »